What drove BP8.AX stock down 50% today?

The drop to **A$0.001** was driven by thin liquidity and heavy sell orders. Volume was **1,111,112**, below average turnover. Weak fundamentals, negative book value and limited news flow amplified the decline.

What is Meyka AI's forecast for BP8.AX stock?

Meyka AI's forecast model projects **A$0.01** over the next quarter for BP8.AX stock, implying **+900.00%** from **A$0.001**. Forecasts are model-based projections and not guarantees.

Is BP8.AX stock a buy after the sell-off?

Given negative book value per share **(-A$0.00209)**, negative cash flow per share and tight liquidity, the stock suits high-risk traders only. Meyka AI grade is **B (HOLD)** — consider waiting for balance-sheet improvement.

Which metrics should I monitor for BP8.AX stock?

Watch daily volume relative to **3,078,160** average, any ASX announcements, current ratio **(0.27)**, cash per share **A$0.00022**, and quarterly revenue updates to assess liquidity and recovery prospects.

AU Stocks

BP8.AX BPH Global Ltd (ASX) down 50% intraday 29 Jan 2026: watch liquidity risk

ByDanny Kontos January 29, 2026January 29, 2026

The BP8.AX stock price fell to A$0.001, down 50.00% intraday on 29 Jan 2026 as trading volume hit 1,111,112 shares on the ASX. This sharp move places BPH Global Ltd (BP8.AX) among today’s top losers and highlights immediate liquidity and valuation concerns for small-cap healthcare names. We break down the intraday drivers, balance-sheet metrics, technicals, Meyka AI grading and a short-term forecast to help investors assess risk and potential upside.